In this study, we confirmed a novel regulatory pathway whereby METTL3 mediates m6A modification-dependent stability of SLC7A11 mRNA via IGF2BP2, sustaining SLC7A11 expression in NPC cells. The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.